China Longyuan Group Limited announced on October 30, 2024, that Zurich Life Insurance Company Limited increased its shareholding in the company's H shares through the Stock Connect II market, reaching a stake of 5%. The purpose of Zurich Life's shareholding this time is based on its recognition of China Longyuan's business philosophy and development strategy, and its bullish outlook on the company's future prospects. During the shareholding process, Zurich Life purchased 4,188,000 shares on October 28, 2024, at a price of HK$7.1723 per share, bringing its total holdings to 417,991,000 shares, accounting for 5% of the company's total share capital. This equity change will not cause any changes to the company's controlling shareholders or actual controllers, nor will it affect the company's independence. China Longyuan will continue to monitor Zurich Life's shareholding changes and fulfill its disclosure obligations in accordance with the law.

China Longyuan Group Limited announced on October 30, 2024, that Zurich Life Insurance Company Limited increased its shareholding in the company's H shares through the Stock Connect II market, reaching a stake of 5%. The purpose of Zurich Life's shareholding this time is based on its recognition of China Longyuan's business philosophy and development strategy, and its bullish outlook on the company's future prospects. During the shareholding process, Zurich Life purchased 4,188,000 shares on October 28, 2024, at a price of HK$7.1723 per share, bringing its total holdings to 417,991,000 shares, accounting for 5% of the company's total share capital. This equity change will not cause any changes to the company's controlling shareholders or actual controllers, nor will it affect the company's independence. China Longyuan will continue to monitor Zurich Life's shareholding changes and fulfill its disclosure obligations in accordance with the law.